HealthSonix Inc. (OTC: HSXI)
HealthSonix Lands First International Sales Contract; Agreement Calls for Purchase of 50,000 Units the First Year
IRVINE, CA--Oct 16, 2006 -- HealthSonix, Inc. (Other OTC:HSXI), (Frankfurt:H7S) -- The Company today announced that it has signed a letter of intent for distribution rights for Mexico. The agreement is with InfoMedica S.A. of Monterey, Mexico. for the exclusive marketing and distribution rights of its enSonix@home medical device. The initial product deliveries will take place in the first quarter of 2007.
"The incidence of arthritis in Mexico is deemed to be the same as that in the rest of the world: at least 30% of the adult population. We are pleased by the amount of interest shown in our products by the international community," stated Dieter Doederlein, Vice president of Corporate Development. "It's an effective, affordable solution for patients suffering with the pain of arthritis." The agreement calls for a minimum of 50,000 enSonix@home units to be sold in the first year of the agreement. This agreement alone represents $4.5 Million in new enSonix@home equipment sales.
The enSonix@home medical device will be available for shipments in the first quarter of 2007. HealthSonix recently registered and cleared the enSonix@home device with the United States Food and Drug Administration (FDA) for the product to be able to be sold in the US market. The enSonix@home is designated as a class one device, the safest classification for medical devices. The product has been indicated for pain reduction and muscle relaxation.
About HealthSonix, Inc.
HealthSonix, Inc. (Other OTC:HSXI.PK - News), (Frankfurt:H7S.F - News) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.
More information regarding HealthSonix and its products and services can be found at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
Contact:
Dieter Doederlein
1-877-622-2121
www.healthsonix.com
View the StockGuru Profile for HealthSonix:
www.stockguru.com/profiles/hsxi/
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 4949 Hedgcoxe, Suite 280, Plano, Texas 75024. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $12,500 from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
To unsubcribe, please click this link:
stockgurunews.com/sendstudio/users/...af6b4d1af657d096cc659c47
You may also email UNSUBCRIBE@STOCKGURU.COM
Zurück
Weiter
